REPATH LAUNCH
15 September 2026
Global
Genspect's REPATH campaign launches with a call to restore psychiatric and psychological assessment for those experiencing transgender ideation. Rather than opposing gender non-conformity, REPATH argues that differential diagnosis must precede any clinical pathway. For Ireland, where the HSE has faced pressure to follow international evidence reviews, the question of whether thorough mental-health evaluation replaces or merely accompanies automatic affirmation is live and consequential.
Genspect, the international organisation co-founded by Stella O'Malley, has formally launched REPATH — its Re-psychopathologisation Campaign — and this episode marks the launch day. O'Malley and fellow host Mia Hughes explain the campaign's central argument: that transgender ideation, distinct from gender non-conformity as a trait or identity, should once again be understood within a psychiatric and psychological framework, one that requires careful differential diagnosis before any clinical intervention takes place. The distinction the campaign insists on is important. REPATH does not propose that gender non-conforming people be treated as disordered. Instead it argues that the internal experience of believing oneself to be the opposite sex — or to have no sex, or a third sex — warrants the same exploratory, evidence-based clinical scrutiny applied to any other presenting psychological phenomenon. The concern driving the campaign is that automatic affirmation models, which took hold across English-speaking countries during the 2010s, short-circuit that process entirely. From an Irish perspective this matters in concrete terms. The gender service at Children's Health Ireland has operated within guidelines that have lagged behind the evidence reviews now reshaping practice in neighbouring jurisdictions. The Cass Review in England, published in 2024, concluded that the evidence base for social and medical transition in children and adolescents was weak and that psychosocial complexity was routinely underassessed. The HSE committed to reviewing its own approach in light of that report. REPATH's launch adds an organised international voice calling for the same reorientation: psychological and psychiatric care as the primary response, not an optional supplement to affirmation. Ireland's Gender Recognition Act 2015 and subsequent policy debates have focused heavily on legal self-identification, but clinical practice for minors sits in a different domain — one governed by medical evidence, professional duty of care, and HSE governance. The gap between progressive legal frameworks and the evidentiary standards appropriate to irreversible medical procedures is precisely the space REPATH seeks to address. For Irish parents, GPs, and mental health professionals navigating referral pathways, a campaign that names differential diagnosis as a requirement rather than an obstacle is a significant development. O'Malley and Hughes bring complementary perspectives to the launch discussion. O'Malley's background as a psychotherapist and her experience founding Genspect give her direct insight into the clinical and organisational arguments underpinning REPATH. Hughes, as a researcher who has tracked international policy shifts in this field, situates the campaign within the broader movement of healthcare bodies stepping back from unqualified affirmation protocols. Together they outline what re-psychopathologisation would look like in practice: not stigma, but structured inquiry, time, and professional skill applied before life-altering decisions are made. For those following how Ireland responds to the post-Cass recalibration happening across Europe and North America, REPATH represents an attempt to give that recalibration a coherent framework and a name. Whether the HSE and Irish professional bodies engage with it will be telling.
